Profit Maximization in the Pharmaceutical Sector

According to Kraetschmer, the drive for profit in the pharmaceutical industry can have negative consequences for patients and public health. Kraetschmer argues that pharmaceutical companies often prioritize profit over the public good, leading to high drug prices and limited access to essential medicines. He notes that pharmaceutical companies spend large amounts of money on marketing and advertising, which can drive up drug prices and contribute to overuse of certain drugs. 

Share this paper